David P. Creekman
Attorney, Attorney at Wyrick Robbins Yates & Ponton
practice group leader of the firm’s Mergers and Acquisitions groupNorth Carolina State BarNorth Carolina Bar AssociationNew York State BarBoard of Directors, American Red Cross Triangle Area Chapter; Philanthropy Committee Chairman (2017-2021)Member, North Carolina Children’s Hospital Board of Visitors (2010-2016)
About
David P. Creekman structures M&A transactions in highly technical and regulated industries at Wyrick Robbins Yates & Ponton. He guides technology and life sciences companies through complex legal and financial issues in their transactions. He practiced with a multinational law firm before joining the firm in 2008. He earned his J.D., cum laude, from New York University School of Law. His M&A clients include private equity and venture capital funds, family offices, and their portfolio companies.
Who is a good fit for David P. Creekman
- Technology and life sciences companies navigating acquisitions in highly technical or regulated industries.
- Private equity funds, venture capital funds, and family offices seeking counsel on complex M&A transactions.
Education and admissions
- Education
- Duke University, B.A.
- New York University School of Law, J.D.
- Bar admissions
- North Carolina, New York
Recognition
- Listed among The Best Lawyers in America: Corporate Law (2021-2027), Corporate Governance Law (2022-2027), Mergers & Acquisitions Law (2026-2027)
- Listed among Business North Carolina Magazine Legal Elite: Business (2022)
- Listed among North Carolina Super Lawyers “Rising Stars” Securities and Corporate Finance (2010, 2012, 2013), Mergers & Acquisitions (2025-2026)
Specialties
Buy-side M&A representationSell-side M&A representationLegal due diligenceEscrow and closing services
Representative matters
As described on the firm’s website.
- Represented leading technology advisory firm in strategic acquisition of Texas-based competitor (buyer side)
- Represented global asset management firm in sales of royalty interests in respect of sales of certain pharmaceutical products to healthcare investment firm
- Represented venture capital fund in its acquisition of innovative laboratory product and component development company (buyer side)
- Represented leading regional office and professional furniture distributor in its acquisition by family office
- Represented leading technology advisory firm in its acquisition by private equity firm
- Represented medical device company in the sale of its newborn screening laboratory solution to a biotechnology company specializing in genetic testing and diagnostics (seller side)
- Represented a leading provider of regulated material management services in a strategic growth investment from a leading healthcare-focused private equity firm
- Represented venture-backed producer of tailored curriculums for clinical trials in sale to private equity sponsor
- Represented developer of biological crop protection products in sale of biofungicide to biopesticide development company (seller side)
Deal profile
- Typical deal size
- Any deal size
- Remote work
- In-person / regional